Biotech Beast

Biotech Beast Biotechnology RXRX Uncategorized

Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead

Mar 2, 2026

Biotech Beast Biotechnology DAWN Uncategorized

Day One Biopharmaceuticals: Commercial Performance With Catalysts Ahead

Feb 27, 2026

Biotech Beast Biotechnology REPL Uncategorized

Replimune: Multiple Shots On Goal But A High Risk Binary Approaches

Feb 21, 2026

Biotech Beast Biotechnology HRTX Uncategorized

Heron: Near The Bottom Of A Trading Range Despite Positives

Feb 18, 2026